Headlands Technologies LLC Buys 1,328 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Headlands Technologies LLC raised its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 16.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,302 shares of the real estate investment trust’s stock after acquiring an additional 1,328 shares during the period. Headlands Technologies LLC’s holdings in Healthpeak Properties were worth $189,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. State Street Corp bought a new stake in shares of Healthpeak Properties in the third quarter worth about $1,093,576,000. Geode Capital Management LLC purchased a new position in Healthpeak Properties during the 3rd quarter valued at approximately $403,898,000. Principal Financial Group Inc. raised its holdings in shares of Healthpeak Properties by 2,113.5% during the 4th quarter. Principal Financial Group Inc. now owns 18,133,812 shares of the real estate investment trust’s stock worth $367,575,000 after acquiring an additional 17,314,572 shares in the last quarter. Norges Bank purchased a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $166,804,000. Finally, JPMorgan Chase & Co. boosted its position in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after acquiring an additional 4,056,931 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 5.3 %

NYSE DOC opened at $18.42 on Friday. The stock has a market cap of $12.89 billion, a PE ratio of 52.63, a PEG ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 12 month low of $17.80 and a 12 month high of $23.26. The company’s 50-day moving average price is $20.11 and its 200-day moving average price is $21.01. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were paid a $0.305 dividend. This is an increase from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a yield of 6.62%. The ex-dividend date was Friday, February 14th. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Robert W. Baird lowered their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Wedbush lowered their price target on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. Wells Fargo & Company reduced their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 10th. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Saturday, March 22nd. Finally, Scotiabank cut their target price on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research report on Friday, February 28th. Four research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Healthpeak Properties currently has an average rating of “Moderate Buy” and a consensus price target of $23.83.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.